Spots Global Cancer Trial Database for childhood acute lymphoblastic leukemia in remission
Every month we try and update this database with for childhood acute lymphoblastic leukemia in remission cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| Infusion of Off-the-Shelf Expanded Cord Blood Cells to Augment Cord Blood Transplant in Patients With Hematologic Malignancies | NCT01175785 | Accelerated Pha... Adult Acute Mye... Adult Acute Mye... Adult Acute Mye... Adult Acute Mye... Adult Acute Mye... Adult Acute Mye... Adult Acute Mye... Childhood Acute... Childhood Acute... Childhood Chron... Childhood Myelo... Chronic Phase C... de Novo Myelody... Previously Trea... Refractory Anem... Refractory Anem... Refractory Anem... Relapsing Chron... Secondary Myelo... | umbilical cord ... fludarabine pho... cyclophosphamid... ex vivo-expande... total-body irra... cyclosporine mycophenolate m... laboratory biom... | 6 Months - 45 Years | Nohla Therapeutics, Inc. | |
| Study to Assess Compliance With Long-Term Mercaptopurine Treatment in Young Patients With Acute Lymphoblastic Leukemia in Remission | NCT00268528 | Childhood Acute... | Compliance Moni... Laboratory Biom... Mercaptopurine Methotrexate Questionnaire A... Study of Socioe... | - 21 Years | Children's Oncology Group | |
| Laboratory Study of Lymphoblasts in Young Patients With High-Risk Acute Lymphoblastic Leukemia | NCT00896766 | Leukemia | loss of heteroz... microarray anal... polymorphism an... tumor replicati... | 1 Year - 21 Years | Children's Oncology Group | |
| Hematopoietic Stem Cell Transplantation in the Treatment of Infant Leukemia | NCT00357565 | Leukemia Myelodysplastic... Childhood Acute... Recurrent Child... Secondary Acute... Childhood Acute... Previously Trea... Secondary Myelo... Refractory Anem... Refractory Anem... Refractory Anem... De Novo Myelody... Childhood Myelo... | filgrastim busulfan cyclosporine fludarabine pho... melphalan mycophenolate m... umbilical cord ... | - 3 Years | Masonic Cancer Center, University of Minnesota | |
| Creating a Decision Support System for the Corporate Management of Physical Therapy | NCT03586401 | Childhood Acute... Childhood Brain... Physical Activi... Physical Disabi... | 4 Years - 18 Years | Federal Research Institute of Pediatric Hematology, Oncology and Immunology | ||
| Vaccine Therapy in Preventing Flu in Children With Acute Lymphoblastic Leukemia | NCT00022035 | Infection Leukemia | trivalent influ... | 1 Year - 20 Years | Roswell Park Cancer Institute | |
| Let's Play! Healthy Kids After Cancer | NCT02361047 | Childhood Acute... Obesity | Phone Coaching ... | 4 Years - 10 Years | HealthPartners Institute | |
| Selective Depletion of CD45RA+T Cells From Allogeneic Peripheral Blood Stem Cell Grafts for the Prevention of GVHD | NCT00914940 | Graft Versus Ho... Leukemia Myelodysplastic... | Fludarabine Pho... Tacrolimus Thiotepa Total-Body Irra... Magnetic Affini... Peripheral Bloo... Allogeneic Hema... T Cell-Depleted... | 14 Years - 55 Years | Fred Hutchinson Cancer Center | |
| Safety Study of Human Myeloid Progenitor Cells (CLT-008) After Cord Blood Transplant for Hematologic Malignancy | NCT00891137 | Leukemia Lymphoma Multiple Myelom... Plasma Cell Neo... Myelodysplastic... | human myeloid p... | 12 Years - 65 Years | Cellerant Therapeutics | |
| Vaccine Therapy in Preventing Flu in Children With Acute Lymphoblastic Leukemia | NCT00022035 | Infection Leukemia | trivalent influ... | 1 Year - 20 Years | Roswell Park Cancer Institute | |
| Imatinib Mesylate After a Donor Stem Cell Transplant in Treating Patients With Philadelphia Chromosome-Positive Leukemia | NCT00244829 | Leukemia | imatinib mesyla... adjuvant therap... | - | Fred Hutchinson Cancer Center | |
| Combination Chemotherapy Followed by Peripheral Stem Cell Transplantation and Interleukin-2 in Treating Patients With Acute Leukemia | NCT00008190 | Leukemia | aldesleukin filgrastim busulfan cyclophosphamid... etoposide melphalan peripheral bloo... | - | National Cancer Institute (NCI) | |
| Chemotherapy, Radiation Therapy, and Umbilical Cord Blood Transplantation in Treating Patients With Hematologic Cancer | NCT00003661 | Graft Versus Ho... Leukemia Lymphoma Myelodysplastic... Neuroblastoma | anti-thymocyte ... busulfan cyclosporine melphalan methylprednisol... umbilical cord ... radiation thera... | - 54 Years | Roswell Park Cancer Institute | |
| ALL-Active: A Family-Based Lifestyle Program for Pediatric Acute Leukemia Patients | NCT01901367 | Childhood Acute... | nutritional int... exercise interv... follow-up care counseling inte... quality-of-life... laboratory biom... questionnaire a... | 2 Years - 18 Years | Vanderbilt-Ingram Cancer Center | |
| Total-Body Irradiation and Fludarabine Phosphate Followed by Donor Peripheral Blood Stem Cell Transplant in Treating Patients With Hematologic Malignancies or Kidney Cancer | NCT00027820 | Adult Acute Mye... Childhood Acute... Childhood Acute... Childhood Myelo... Childhood Renal... Chronic Myelomo... Clear Cell Rena... de Novo Myelody... Metastatic Rena... Previously Trea... Progression of ... Recurrent Adult... Recurrent Adult... Recurrent Adult... Recurrent Adult... Recurrent Adult... Recurrent Child... Recurrent Child... Recurrent Child... Recurrent Child... Refractory Anem... Refractory Anem... Refractory Chil... Refractory Chro... Renal Medullary... Type 1 Papillar... Type 2 Papillar... Untreated Adult... Untreated Adult... Untreated Child... | Fludarabine Pho... Total-Body Irra... Peripheral Bloo... Nonmyeloablativ... Cyclosporine Mycophenolate M... | - | Fred Hutchinson Cancer Center | |
| Selective Depletion of CD45RA+T Cells From Allogeneic Peripheral Blood Stem Cell Grafts for the Prevention of GVHD | NCT00914940 | Graft Versus Ho... Leukemia Myelodysplastic... | Fludarabine Pho... Tacrolimus Thiotepa Total-Body Irra... Magnetic Affini... Peripheral Bloo... Allogeneic Hema... T Cell-Depleted... | 14 Years - 55 Years | Fred Hutchinson Cancer Center | |
| Creating a Decision Support System for the Corporate Management of Physical Therapy | NCT03586401 | Childhood Acute... Childhood Brain... Physical Activi... Physical Disabi... | 4 Years - 18 Years | Federal Research Institute of Pediatric Hematology, Oncology and Immunology | ||
| Neurobehavioral Complications in Children Who Were Previously Treated With Steroids and Intrathecal Therapy for Acute Lymphoblastic Leukemia | NCT00085176 | Leukemia Long-term Effec... Neurotoxicity Psychosocial Ef... | management of t... psychosocial as... | 6 Years - 16 Years | Children's Oncology Group | |
| Combination Chemotherapy in Treating Children With Acute Lymphoblastic Leukemia | NCT00005603 | Leukemia | asparaginase cyclophosphamid... cytarabine daunorubicin hy... dexamethasone doxorubicin hyd... mercaptopurine methotrexate prednisone thioguanine vincristine sul... | 1 Year - 21 Years | Children's Oncology Group | |
| DNA Analysis of Tissue From Patients With T-Cell Acute Lymphoblastic Leukemia | NCT00899366 | Leukemia | microarray anal... mutation analys... immunologic tec... | 18 Years - 120 Years | Eastern Cooperative Oncology Group | |
| Study of Biomarkers in DNA Samples From Patients With Acute Lymphoblastic Leukemia or Acute Myeloid Leukemia | NCT01005277 | Adult Acute Mye... Adult Acute Mye... Adult Acute Pro... Childhood Acute... Childhood Acute... Childhood Acute... Recurrent Child... Recurrent Child... Secondary Acute... | Laboratory Biom... | - | Children's Oncology Group | |
| Selective Depletion of CD45RA+ T Cells From Allogeneic Peripheral Blood Stem Cell Grafts in Preventing GVHD in Children | NCT01858740 | Accelerated Pha... Acute Biphenoty... Acute Leukemia ... Acute Undiffere... Adult Acute Lym... Adult Acute Mye... Blast Phase Chr... Childhood Acute... Childhood Acute... Chronic Myeloge... Myelodysplastic... Myelodysplastic... Recurrent Adult... Recurrent Adult... Recurrent Child... Recurrent Child... Refractory Adul... Refractory Chil... | Allogeneic Hema... Fludarabine Pho... Laboratory Biom... Methotrexate Peripheral Bloo... T Cell-Depleted... Tacrolimus Thiotepa Total-Body Irra... | - 21 Years | Fred Hutchinson Cancer Center | |
| Total-Body Irradiation, Thiotepa, and Fludarabine in Treating Young Patients Who Are Undergoing a Donor Stem Cell Transplant for Hematologic Cancer | NCT00112567 | Leukemia Myelodysplastic... | fludarabine pho... thiotepa peripheral bloo... radiation thera... | - 20 Years | Fred Hutchinson Cancer Center | |
| Response or Resistance to Chemotherapy in Young Patients With Acute Lymphoblastic Leukemia Treated With Methotrexate | NCT00898404 | B-cell Childhoo... Childhood Acute... Recurrent Child... T-cell Childhoo... | laboratory biom... | - 17 Years | Children's Oncology Group | |
| Chemotherapy and Total-Body Irradiation Followed by Donor Umbilical Cord Blood Transplant, Cyclosporine, and Mycophenolate Mofetil in Treating Patients With Hematologic Cancer | NCT00290641 | Chronic Myelopr... Leukemia Lymphoma Myelodysplastic... | filgrastim graft-versus-tu... cyclophosphamid... cyclosporine fludarabine pho... mycophenolate m... umbilical cord ... radiation thera... | - 45 Years | Masonic Cancer Center, University of Minnesota | |
| Combination Chemotherapy With or Without Peripheral Stem Cell Transplant in Treating Children With Acute Lymphoblastic Leukemia | NCT00022737 | Childhood Acute... Recurrent Child... | filgrastim asparaginase cyclophosphamid... cyclosporine cytarabine daunorubicin hy... dexamethasone etoposide ifosfamide imatinib mesyla... leucovorin calc... mercaptopurine ... methotrexate pegaspargase vincristine sul... allogeneic bone... peripheral bloo... umbilical cord ... radiation thera... | 1 Year - 21 Years | National Cancer Institute (NCI) | |
| Chemotherapy, Radiation Therapy, and Umbilical Cord Blood Transplantation in Treating Patients With Hematologic Cancer | NCT00003661 | Graft Versus Ho... Leukemia Lymphoma Myelodysplastic... Neuroblastoma | anti-thymocyte ... busulfan cyclosporine melphalan methylprednisol... umbilical cord ... radiation thera... | - 54 Years | Roswell Park Cancer Institute | |
| Donor Peripheral Stem Cell Transplant and Donor Natural Killer Cell Transplant After Total-Body Irradiation, Thiotepa, Fludarabine, and Muromonab-CD3 in Treating Patients With Leukemia or Other Blood Diseases | NCT00450983 | Graft Versus Ho... Leukemia Myelodysplastic... | muromonab-CD3 natural killer ... fludarabine pho... methotrexate thiotepa gene expression... flow cytometry immunologic tec... allogeneic hema... in vitro-treate... total-body irra... | - 45 Years | Fred Hutchinson Cancer Center | |
| Study of Metabolic Syndrome in Young Patients Who Are Acute Lymphoblastic Leukemia Survivors and Their Healthy Siblings | NCT00897078 | Leukemia | laboratory biom... medical chart r... metabolic asses... questionnaire a... assessment of t... | 8 Years - 21 Years | Vanderbilt University | |
| Quality of Life of Adult Cancer Survivors Who Have Undergone a Previous Bone Marrow or Peripheral Stem Cell Transplant for a Childhood Hematologic Cancer | NCT00126477 | Leukemia Lymphoma Myelodysplastic... Quality of Life | cognitive asses... management of t... psychosocial as... quality-of-life... | 18 Years - | Fred Hutchinson Cancer Center | |
| Chemotherapy With or Without Total-Body Irradiation Prior to Bone Marrow Transplantation in Treating Children With Acute Lymphoblastic Leukemia | NCT00002961 | Leukemia | cyclophosphamid... cyclosporine etoposide methotrexate allogeneic bone... Total Body Irra... Busulfan Mesna Radiation | - 21 Years | Children's Hospital of Philadelphia | |
| ALL-Active: A Family-Based Lifestyle Program for Pediatric Acute Leukemia Patients | NCT01901367 | Childhood Acute... | nutritional int... exercise interv... follow-up care counseling inte... quality-of-life... laboratory biom... questionnaire a... | 2 Years - 18 Years | Vanderbilt-Ingram Cancer Center | |
| Chemotherapy With or Without Total-Body Irradiation Prior to Bone Marrow Transplantation in Treating Children With Acute Lymphoblastic Leukemia | NCT00002961 | Leukemia | cyclophosphamid... cyclosporine etoposide methotrexate allogeneic bone... Total Body Irra... Busulfan Mesna Radiation | - 21 Years | Children's Hospital of Philadelphia | |
| Selective Depletion of CD45RA+ T Cells From Allogeneic Peripheral Blood Stem Cell Grafts From HLA-Matched Related and Unrelated Donors in Preventing GVHD | NCT02220985 | Accelerated Pha... Acute Biphenoty... Acute Leukemia ... Acute Undiffere... Allogeneic Hema... Blast Phase Chr... Blastic Plasmac... Childhood Acute... Childhood Acute... Donor Lymphoblastic L... Myelodysplastic... Myelodysplastic... Myelodysplastic... Recurrent Acute... Recurrent Acute... Recurrent Child... Recurrent Child... Recurrent Chron... Refractory Acut... Refractory Acut... Acute Lymphobla... Acute Myeloid L... | Allogeneic Hema... Cyclophosphamid... Fludarabine Pho... Laboratory Biom... Methotrexate Mycophenolate M... Peripheral Bloo... Peripheral Bloo... Tacrolimus Thiotepa Total-Body Irra... | - 60 Years | Fred Hutchinson Cancer Center | |
| Imatinib Mesylate After a Donor Stem Cell Transplant in Treating Patients With Philadelphia Chromosome-Positive Leukemia | NCT00244829 | Leukemia | imatinib mesyla... adjuvant therap... | - | Fred Hutchinson Cancer Center | |
| Helical Tomotherapy, Fludarabine Phosphate, and Melphalan Followed By Allo-HSCT in Hematological Malignancies | NCT00544466 | Leukemia Myelodysplastic... | fludarabine pho... melphalan allogeneic hema... intensity-modul... | 7 Years - | City of Hope Medical Center | |
| Donor Bone Marrow Transplant With or Without G-CSF in Treating Young Patients With Hematologic Cancer or Other Diseases | NCT00450450 | Childhood Acute... Childhood Acute... Childhood Chron... Childhood Myelo... Chronic Phase C... de Novo Myelody... Juvenile Myelom... Previously Trea... Recurrent Child... Secondary Myelo... | allogeneic bone... laboratory biom... filgrastim | - 21 Years | Children's Oncology Group | |
| Laboratory-Treated Lymphocyte Infusion After Haploidentical Donor Stem Cell Transplant | NCT00376480 | Leukemia Myelodysplastic... | anti-thymocyte ... peripheral bloo... fludarabine pho... methylprednisol... thiotepa allogeneic hema... in vitro-treate... total-body irra... | - 50 Years | Dana-Farber Cancer Institute | |
| Donor Stem Cell Transplant in Treating Young Patients With Myelodysplastic Syndrome, Leukemia, Bone Marrow Failure Syndrome, or Severe Immunodeficiency Disease | NCT00295971 | Congenital Ameg... Leukemia Myelodysplastic... Severe Congenit... | anti-thymocyte ... therapeutic all... fludarabine pho... thiotepa allogeneic bone... allogeneic hema... in vitro-treate... total-body irra... | 1 Year - 17 Years | University of California, San Francisco | |
| Combination Chemotherapy and Total-Body Irradiation Followed by Peripheral Stem Cell or Bone Marrow Transplantation in Treating Patients With Acute Lymphoblastic Leukemia | NCT00027547 | Leukemia | therapeutic all... cyclosporine cytarabine fludarabine pho... methotrexate mycophenolate m... allogeneic bone... peripheral bloo... radiation thera... | - 75 Years | Fred Hutchinson Cancer Center | |
| Metabolic Syndrome in Young Patients With Acute Lymphoblastic Leukemia in Remission | NCT00801346 | Fatigue Leukemia Long-term Effec... | laboratory biom... metabolic asses... questionnaire a... assessment of t... fatigue assessm... quality-of-life... | 1 Year - 20 Years | Vanderbilt University Medical Center | |
| Laboratory-Treated Lymphocyte Infusion After Haploidentical Donor Stem Cell Transplant | NCT00376480 | Leukemia Myelodysplastic... | anti-thymocyte ... peripheral bloo... fludarabine pho... methylprednisol... thiotepa allogeneic hema... in vitro-treate... total-body irra... | - 50 Years | Dana-Farber Cancer Institute | |
| Selective Depletion of CD45RA+ T Cells From Allogeneic Peripheral Blood Stem Cell Grafts in Preventing GVHD in Children | NCT01858740 | Accelerated Pha... Acute Biphenoty... Acute Leukemia ... Acute Undiffere... Adult Acute Lym... Adult Acute Mye... Blast Phase Chr... Childhood Acute... Childhood Acute... Chronic Myeloge... Myelodysplastic... Myelodysplastic... Recurrent Adult... Recurrent Adult... Recurrent Child... Recurrent Child... Refractory Adul... Refractory Chil... | Allogeneic Hema... Fludarabine Pho... Laboratory Biom... Methotrexate Peripheral Bloo... T Cell-Depleted... Tacrolimus Thiotepa Total-Body Irra... | - 21 Years | Fred Hutchinson Cancer Center | |
| Bone Marrow Transplantation in Treating Patients With Leukemia | NCT00006451 | Graft Versus Ho... Leukemia Lymphoma | anti-thymocyte ... cyclophosphamid... cyclosporine methotrexate methylprednisol... allogeneic bone... in vitro-treate... radiation thera... | - 45 Years | Masonic Cancer Center, University of Minnesota | |
| Genetic Test To Identify Previously Undetectable Minimal Residual Disease in Cell Samples From Younger Patients With Acute Lymphoblastic Leukemia | NCT01533168 | Leukemia | cytogenetic ana... nucleic acid se... diagnostic labo... laboratory biom... medical chart r... | 1 Year - 30 Years | Children's Oncology Group | |
| Metabolic Syndrome in Young Patients With Acute Lymphoblastic Leukemia in Remission | NCT00801346 | Fatigue Leukemia Long-term Effec... | laboratory biom... metabolic asses... questionnaire a... assessment of t... fatigue assessm... quality-of-life... | 1 Year - 20 Years | Vanderbilt University Medical Center | |
| Study to Assess Compliance With Long-Term Mercaptopurine Treatment in Young Patients With Acute Lymphoblastic Leukemia in Remission | NCT00268528 | Childhood Acute... | Compliance Moni... Laboratory Biom... Mercaptopurine Methotrexate Questionnaire A... Study of Socioe... | - 21 Years | Children's Oncology Group | |
| Studying Biomarkers as a Diagnostic Tool in Samples From Younger Patients With B-Cell Acute Lymphoblastic Leukemia | NCT01540578 | B-cell Childhoo... Childhood Acute... Recurrent Child... | laboratory biom... | - | Children's Oncology Group | |
| Combination Chemotherapy Followed by Peripheral Stem Cell Transplantation and Interleukin-2 in Treating Patients With Acute Leukemia | NCT00008190 | Leukemia | aldesleukin filgrastim busulfan cyclophosphamid... etoposide melphalan peripheral bloo... | - | National Cancer Institute (NCI) | |
| Tacrolimus and Methotrexate With or Without Sirolimus in Preventing Graft-Versus-Host Disease in Young Patients Undergoing Donor Stem Cell Transplant for Acute Lymphoblastic Leukemia in Complete Remission | NCT00382109 | B-cell Childhoo... Childhood Acute... Graft Versus Ho... L1 Childhood Ac... L2 Childhood Ac... T-cell Childhoo... | thiotepa cyclophosphamid... tacrolimus methotrexate sirolimus total body irra... | 1 Year - 21 Years | Children's Oncology Group | |
| Total-Body Irradiation, Thiotepa, and Fludarabine in Treating Young Patients Who Are Undergoing a Donor Stem Cell Transplant for Hematologic Cancer | NCT00112567 | Leukemia Myelodysplastic... | fludarabine pho... thiotepa peripheral bloo... radiation thera... | - 20 Years | Fred Hutchinson Cancer Center | |
| Radiation Therapy to the Head or Intrathecal Chemotherapy Plus High Dose Cytarabine in Preventing CNS Disease in Children With Acute Lymphoblastic Leukemia | NCT00019409 | Leukemia | asparaginase cyclophosphamid... cytarabine daunorubicin hy... mercaptopurine methotrexate prednisone therapeutic hyd... vincristine sul... radiation thera... | 1 Year - 20 Years | National Institutes of Health Clinical Center (CC) | |
| Biomarker Study in Bone Marrow Samples From Patients With T-Cell Acute Lymphoblastic Leukemia | NCT01295476 | Leukemia | gene expression... microarray anal... laboratory biom... | 1 Year - 30 Years | Children's Oncology Group | |
| Response or Resistance to Chemotherapy in Young Patients With Acute Lymphoblastic Leukemia Treated With Methotrexate | NCT00898404 | B-cell Childhoo... Childhood Acute... Recurrent Child... T-cell Childhoo... | laboratory biom... | - 17 Years | Children's Oncology Group | |
| Creating a Decision Support System for the Corporate Management of Physical Therapy | NCT03586401 | Childhood Acute... Childhood Brain... Physical Activi... Physical Disabi... | 4 Years - 18 Years | Federal Research Institute of Pediatric Hematology, Oncology and Immunology | ||
| Study of Metabolic Syndrome in Adolescent and Young Adult Survivors of Childhood Leukemia Who Have Undergone Stem Cell Transplant | NCT00920842 | Cardiovascular ... Leukemia Long-term Effec... Metabolic Syndr... | 9 Years - 21 Years | Fred Hutchinson Cancer Center | ||
| Monoclonal Antibody Therapy, Cyclophosphamide, and Total-Body Irradiation Followed by Peripheral Stem Cell Transplantation in Treating Patients With Advanced Recurrent Acute Lymphocytic Leukemia | NCT00003870 | Leukemia | cyclophosphamid... methotrexate allogeneic bone... iodine I 131 mo... radiation thera... | 2 Years - 55 Years | Fred Hutchinson Cancer Center | |
| Two Combination Chemotherapy Regimens in Treating Children With Newly Diagnosed Acute Lymphoblastic Leukemia | NCT00707083 | Leukemia | dexamethasone mercaptopurine methotrexate vincristine sul... | - 17 Years | Prince of Wales Hospital, Shatin, Hong Kong | |
| Study of Long-Term Outcomes of Patients With Acute Lymphoblastic Leukemia Who Were Enrolled as Children on Clinical Trials EORTC-58741, EORTC-58831, EORTC-58832, or EORTC-58881 Between 1971 and 1998 | NCT01298388 | Cancer Survivor Leukemia Long-term Effec... | medical chart r... questionnaire a... study of socioe... | - 17 Years | National Cancer Institute (NCI) | |
| Safety Study of Human Myeloid Progenitor Cells (CLT-008) After Cord Blood Transplant for Hematologic Malignancy | NCT00891137 | Leukemia Lymphoma Multiple Myelom... Plasma Cell Neo... Myelodysplastic... | human myeloid p... | 12 Years - 65 Years | Cellerant Therapeutics | |
| Ex Vivo Expansion of Mafosfamide Purged CD34+ Cells in Patients With Acute Leukemia | NCT00245115 | Leukemia | filgrastim busulfan cyclophosphamid... in vitro-treate... in vitro-treate... | - 70 Years | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | |
| Bone Marrow Transplantation in Treating Patients With Acute Leukemia in First or Second Remission | NCT00002534 | Leukemia | anti-thymocyte ... cyclophosphamid... cytarabine methylprednisol... thiotepa allogeneic bone... in vitro-treate... low-LET electro... low-LET photon ... | - | Memorial Sloan Kettering Cancer Center | |
| Monoclonal Antibody Therapy, Cyclophosphamide, and Total-Body Irradiation Followed by Peripheral Stem Cell Transplantation in Treating Patients With Advanced Recurrent Acute Lymphocytic Leukemia | NCT00003870 | Leukemia | cyclophosphamid... methotrexate allogeneic bone... iodine I 131 mo... radiation thera... | 2 Years - 55 Years | Fred Hutchinson Cancer Center | |
| Donor Bone Marrow Transplant With or Without G-CSF in Treating Young Patients With Hematologic Cancer or Other Diseases | NCT00450450 | Childhood Acute... Childhood Acute... Childhood Chron... Childhood Myelo... Chronic Phase C... de Novo Myelody... Juvenile Myelom... Previously Trea... Recurrent Child... Secondary Myelo... | allogeneic bone... laboratory biom... filgrastim | - 21 Years | Children's Oncology Group | |
| Combination Chemotherapy in Treating Children With Acute Lymphoblastic Leukemia | NCT00005585 | Leukemia | cyclophosphamid... cytarabine daunorubicin hy... dexamethasone leucovorin calc... mercaptopurine methotrexate pegaspargase thioguanine vincristine sul... | 1 Year - 9 Years | Children's Oncology Group | |
| Filgrastim-Treated Donor Peripheral Stem Cell Transplantation in Treating Patients With Acute Leukemia</p> | NCT00025545 | Leukemia | cyclophosphamid... methotrexate peripheral bloo... radiation thera... | - 55 Years | Fred Hutchinson Cancer Center | |
| Radiation Therapy and Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Patients With High-Grade Lymphoma or Acute Lymphoblastic Leukemia | NCT00004898 | Leukemia Lymphoma | filgrastim cyclophosphamid... etoposide peripheral bloo... radiation thera... | - 65 Years | Northwestern University | |
| Treosulfan, Fludarabine Phosphate, and Total-Body Irradiation Before Donor Stem Cell Transplant in Treating Patients With High-Risk Acute Myeloid Leukemia, Myelodysplastic Syndrome, Acute Lymphoblastic Leukemia | NCT00860574 | Accelerated Pha... Adult Acute Lym... Adult Acute Mye... Adult Acute Mye... Adult Acute Mye... Adult Acute Mye... Adult Acute Mye... Adult Acute Mye... Adult Acute Mye... Blastic Phase C... Childhood Acute... Childhood Acute... Childhood Chron... Childhood Myelo... Chronic Myelomo... de Novo Myelody... Previously Trea... Recurrent Adult... Recurrent Adult... Recurrent Child... Recurrent Child... Secondary Myelo... Untreated Adult... Untreated Child... | treosulfan fludarabine pho... total-body irra... peripheral bloo... tacrolimus allogeneic bone... allogeneic hema... methotrexate | - 60 Years | Fred Hutchinson Cancer Center | |
| Fludarabine Phosphate and Total-Body Irradiation Followed by Donor Peripheral Blood Stem Cell Transplant in Treating Patients With Acute Lymphoblastic Leukemia or Chronic Myelogenous Leukemia That Has Responded to Treatment With Imatinib Mesylate, Dasatinib, or Nilotinib | NCT00036738 | Adult Acute Lym... Adult B Acute L... Blastic Phase Childhood Acute... Childhood B Acu... Chronic Myeloge... Chronic Phase o... Recurrent Adult... Recurrent Child... Recurrent Disea... | Cyclosporine Dasatinib Fludarabine Pho... Imatinib Mesyla... Mycophenolate M... Nilotinib Nonmyeloablativ... Peripheral Bloo... Therapeutic All... Total-Body Irra... | - 70 Years | Fred Hutchinson Cancer Center | |
| Combination Chemotherapy in Treating Children With Acute Lymphoblastic Leukemia | NCT00005603 | Leukemia | asparaginase cyclophosphamid... cytarabine daunorubicin hy... dexamethasone doxorubicin hyd... mercaptopurine methotrexate prednisone thioguanine vincristine sul... | 1 Year - 21 Years | Children's Oncology Group | |
| DNA Analysis of Tissue From Patients With T-Cell Acute Lymphoblastic Leukemia | NCT00899366 | Leukemia | microarray anal... mutation analys... immunologic tec... | 18 Years - 120 Years | Eastern Cooperative Oncology Group | |
| Clofarabine and High-Dose Melphalan Followed by Donor Stem Cell Transplant in Patients With Acute Myeloid Leukemia, Acute Lymphocytic Leukemia, or Myelodysplastic Syndromes | NCT00641030 | Leukemia Myelodysplastic... | clofarabine melphalan gene expression... reverse transcr... flow cytometry laboratory biom... allogeneic hema... | 1 Year - 120 Years | City of Hope Medical Center | |
| Culturally Adapted Parenting Intervention for Spanish-Speaking Parents in Improving Outcomes of Younger Acute Lymphoblastic Leukemia or Acute Myeloid Leukemia Survivors at Risk for Late Neurocognitive Effects | NCT02559557 | Cancer Survivor Childhood Acute... Childhood Acute... Cognitive Side ... | Educational Int... Educational Int... Quality-of-Life... Questionnaire A... | - | City of Hope Medical Center | |
| Combination Chemotherapy With or Without Peripheral Stem Cell Transplant in Treating Children With Acute Lymphoblastic Leukemia | NCT00022737 | Childhood Acute... Recurrent Child... | filgrastim asparaginase cyclophosphamid... cyclosporine cytarabine daunorubicin hy... dexamethasone etoposide ifosfamide imatinib mesyla... leucovorin calc... mercaptopurine ... methotrexate pegaspargase vincristine sul... allogeneic bone... peripheral bloo... umbilical cord ... radiation thera... | 1 Year - 21 Years | National Cancer Institute (NCI) | |
| DNA Analysis of Tumor Tissue Samples From Young Patients With Acute Lymphoblastic Leukemia | NCT00897507 | Childhood Acute... Recurrent Child... | Laboratory Biom... | - 18 Years | Children's Oncology Group | |
| Bone Marrow Transplantation in Treating Patients With Hematologic Cancer | NCT00005854 | Leukemia Lymphoma Multiple Myelom... Myelodysplastic... | cyclophosphamid... cyclosporine methotrexate allogeneic bone... in vitro-treate... radiation thera... | - 50 Years | Fred Hutchinson Cancer Center | |
| Selective Depletion of CD45RA+T Cells From Allogeneic Peripheral Blood Stem Cell Grafts for the Prevention of GVHD | NCT00914940 | Graft Versus Ho... Leukemia Myelodysplastic... | Fludarabine Pho... Tacrolimus Thiotepa Total-Body Irra... Magnetic Affini... Peripheral Bloo... Allogeneic Hema... T Cell-Depleted... | 14 Years - 55 Years | Fred Hutchinson Cancer Center | |
| Resistance to Methotrexate in Patients With Acute Lymphoblastic Leukemia in Relapse or Remission | NCT00899899 | Leukemia | microarray anal... reverse transcr... laboratory biom... | - 120 Years | Children's Oncology Group | |
| Total-Body Irradiation, Thiotepa, and Fludarabine in Treating Young Patients Who Are Undergoing a Donor Stem Cell Transplant for Hematologic Cancer | NCT00112567 | Leukemia Myelodysplastic... | fludarabine pho... thiotepa peripheral bloo... radiation thera... | - 20 Years | Fred Hutchinson Cancer Center |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
